Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s10067-020-05189-y http://scihub22266oqcxt.onion/10.1007/s10067-020-05189-y 32472461!7256179!32472461     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Rheumatol 2020 ; 39 (7): 2069-2075 Nephropedia Template TP {{tp|p=32472461|t=2020. COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments |pdf=|usr=}}{{32472461}} gab.com Text COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments JO: Clin Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=32472461 #FOAvip Since December 2019, the pandemic caused by coronavirus disease 2019 (COVID-19) raises a real public health problem. COVID-19 appeared in Wuhan (Hubei province) in China. Drugs that have been used in rheumatology for decades seem to be effective in this infection and are for the most part being studied. The rational use of these anti-rheumatic drugs is based on the cytokinic storm (hyperproduction of IL1, IL6, TNF alpha) in the body by COVID-19 in its severe form. In this review, the authors make the difference between the infectious and auto-inflammatory part of COVID-19; the disease does not seem to be a risk factor for admission to the intensive care unit for patients suffering from inflammatory rheumatism; however, the poverty of studies on this subject should be noted. The authors also review anti-rheumatic drugs while studying COVID-19 treatment. Twit Text FOAVip COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments ????Clin Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=32472461 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32472461 #FOAvip English Wikipedia <ref>{{Cite pmid|32472461}}</ref> COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments #MMPMID32472461 Ouedraogo DD; Tiendrebeogo WJS; Kabore F; Ntsiba H Clin Rheumatol 2020[Jul]; 39 (7): 2069-2075 PMID32472461show ga Since December 2019, the pandemic caused by coronavirus disease 2019 (COVID-19) raises a real public health problem. COVID-19 appeared in Wuhan (Hubei province) in China. Drugs that have been used in rheumatology for decades seem to be effective in this infection and are for the most part being studied. The rational use of these anti-rheumatic drugs is based on the cytokinic storm (hyperproduction of IL1, IL6, TNF alpha) in the body by COVID-19 in its severe form. In this review, the authors make the difference between the infectious and auto-inflammatory part of COVID-19; the disease does not seem to be a risk factor for admission to the intensive care unit for patients suffering from inflammatory rheumatism; however, the poverty of studies on this subject should be noted. The authors also review anti-rheumatic drugs while studying COVID-19 treatment. |*Coronavirus Infections/drug therapy/epidemiology/immunology[MESH] |*Pandemics[MESH] |*Pneumonia, Viral/drug therapy/epidemiology/immunology[MESH] |*Rheumatic Diseases/drug therapy/epidemiology/immunology[MESH] |Antirheumatic Agents/*pharmacology[MESH] |Betacoronavirus/isolation & purification[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |Comorbidity[MESH] |Humans[MESH]COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic tr(epmc).pdf DeepDyve Pubget Overpricing